Canadian AIDS Treatment Information Exchange
Click here to return to CATIE main menu
DonateNow

TreatmentUpdate: Bactrim/Septra does not always prevent bacterial lung infections

TreatmentUpdate 75. 9(1): 2-3; January, 1997
Sean Hosein


Background

Bacteria pneumonia (BP) is a complication that can occur in people with HIV/AIDS (PHAs). Some studies have found that PHAs taking the antibiotic Bactrim/Septra(R) to prevent PCP are also protected from BP. Doctors in Italy reviewed their hospital records to find out which of their HIV-infected patients taking Bactrim/Septra developed BP.

Study Details

Reviewing records from 1990 to 1995, the doctors found ?167 HIV-infected patients? who had BP. Nearly 80% were injection drug users; 35% were female and 65% male. Patients who had less than 200 CD4+ cells were at increased risk of BP compared to others who had more than 200 cells.

The doctors compared records from each of their patients with BP who had used some form of PCP prevention:

with records from two other PHAs who:

Results

Comparing the two groups of patients, the doctors found that subjects receiving Bactrim/Septra were less likely to develop BP. However, not every patient using Bactrim/Septra was protected from BP. Patients who had recovered from an episode of PCP and then began taking Bactrim/Septra to prevent another episode of PCP, were just as likely to develop BP as patients who used dapsone-pyrimethamine or aerosol pentamidine.

Why?

The researchers think that once a person has an episode of PCP, their lungs may be damaged, making it easier for bacteria to infect. As well, certain "immune defences" that can contain BP weaken over time. Bactrim/Septra is very useful--providing some protection from PCP and the life-threatening brain infection toxo (toxoplasmosis). PHAs who have had an episode of PCP and who use Bactrim/Septra are still at risk of BP. Perhaps doctors may wish to provide more intensive monitoring for such patients and consider the use of additional antibiotics.

REFERENCE:

1. Tumbarello M, Tacconelli E, Cauda R and Ortona L. Secondary pneumocystis carinii pneumonia prophylaxis with trimethoprim-sulphamethoxazole does not prevent bacterial pneumonia in HIV-infected persons. AIDS 1996; 10(13): 1603-1604.

970120
CATE7502


ÆGIS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. This article first appeard in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

Copyright © 1997 - TreatmentUpdate. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Editor, The Canadian AIDS Treatment Information Exchange, 555 Richmond St. West, Suite 505, Box 1104, Toronto, ON, M5V 3B1 • Phone: 416-203-7122 • Toll Free: 1-800-263-1638 • Fax: 416-203-8284  http://www.catie.ca


Disclaimer: The editors have taken all such care as they consider reasonable in preparing this database, but they cannot be held responsible for any inaccuracies or mis-statements of fact contained herein. Inclusion in this database of any information on any treatment, therapy, or clinical trial in no way represents an endorsement of that treatment, therapy, or trial by ÆGiS or any of its sponsors. This data should always be used in conjunction with professional medical advice.
©1997. ÆGiS.